Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEC block for pain control after radical mastectomy with axillary approach
RBR-79ysyy6Recruiting
- Sponsor
- Santa Casa de Maceió
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of levobupivacaine in breast cancer (2 arms), sponsored by Santa Casa de Maceió. Primary endpoint: Postoperative pain intensity at 24 hours. Started Mar 2020; status: recruiting.
02
Drugs
levobupivacaine
03
Conditions
breast cancer
Beyond the preview
Go deeper on RBR-79ysyy6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-79ysyy6.